Diabetes cure could be step closer: study

Image
Press Trust of India Boston
Last Updated : Jan 26 2016 | 1:57 PM IST
Diabetes may soon be cured after scientists have managed to halt the condition in mice for six months, thanks to the use of insulin-producing cells that had been generated from human stem cells.
Experts from US hospitals and institutions including Harvard University managed to transplant cells into mice, which immediately began producing insulin.
The team was also able to show they could prevent the cells being rendered useless by the body's own immune system, which was effectively "switched off" thanks to scientific work.
It means a cure for type 1 diabetes - which affects 400,000 people in the UK - could be much closer. Scientists are now working to replicate the results in humans with the condition.
The findings build on the news at the end of 2014 that experts had discovered how to make huge quantities of insulin-producing cells.
The man who led that breakthrough - Harvard Professor Doug Melton, who has been trying to find a cure for the disease since his son was diagnosed with type 1 diabetes as a baby - also worked on the new studies.
The human islet cells used for the new research were generated from human stem cells developed by Professor Melton.
"Encapsulation therapies have the potential to be groundbreaking for people with type 1 diabetes.
"These treatments aim to effectively establish long-term insulin independence and eliminate the daily burden of managing the disease for months, possibly years, at a time without the need for immune suppression," said Juvenile Diabetes Research Foundation (JDRF) vice-president of discovery research, Julia Greenstein.
The findings are published in the journals Nature Medicine and Nature Biotechnology and were made possible with funding from JDRF.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 26 2016 | 1:57 PM IST

Next Story